Clinical Practice

Use the tool below to view all available Global Neurology Academy Series

Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiers
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
NeuroFrontiers
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
- Charles Turck, PharmD, BCPS, BCCCP
- Jason Ackrivo, MD, MSCE
- Bethany Lussier, MD
Mapping Brain Atrophy in Schizophrenia
Mapping Brain Atrophy in Schizophrenia
Neurology and Neurosurgery
Mapping Brain Atrophy in Schizophrenia
- Ahmed Makhlouf, MD
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
Global Neurology Academy
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
- Marisa McGinley, DO
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Global Neurology Academy
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
- Charles Turck, PharmD, BCPS, BCCCP
- Kimberly DiMauro, DO
- Carol Swetlik, MD
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Global Neurology Academy
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
- Joseph F. Goldberg, MD
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Global Neurology Academy
Understanding Schizophrenia: Early Intervention and Prevention Strategies
- Joseph F. Goldberg, MD
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiers
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
- Michael G. Dwyer, PhD
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
- Michael G. Dwyer, PhD
Studying Cortical Lesions in MS: Future Research Directions
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiers
Studying Cortical Lesions in MS: Future Research Directions
- Michael G. Dwyer, PhD
From Diagnosis to Treatment: Challenges in Glioblastoma Care
From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
- Lauren Schaff, MD
Climate Change in the Clinic: Examining Neurological Impacts
Climate Change in the Clinic: Examining Neurological Impacts
NeuroFrontiers
Climate Change in the Clinic: Examining Neurological Impacts
- Beth Ann Malow, MD, MS
Optimizing TK2d Care Through a Multidisciplinary Approach
Optimizing TK2d Care Through a Multidisciplinary Approach
NeuroFrontiers
Optimizing TK2d Care Through a Multidisciplinary Approach
- Charles Turck, PharmD, BCPS, BCCCP
- Kaitlin Batley, MD
- Esra Caylan, MD
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Global Neurology Academy
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
- Sami Khella, MD
Genetics in Schizophrenia Management: Emerging Technological Strategies
Genetics in Schizophrenia Management: Emerging Technological Strategies
Psychiatry and Mental Health
Genetics in Schizophrenia Management: Emerging Technological Strategies
- Aaron Besterman, MD
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiers
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
- Craig M. McDonald, MD

Clinical Practice

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Clinical Practice

Popular

Title

Share on ReachMD